openPR Logo
Press release

Next-generation Sequencing Market

06-19-2017 04:47 PM CET | Health & Medicine

Press release from: Biotechnology Industry Report By CMI

Next-generation sequencing or high throughput sequencing are advanced DNA sequencing technologies, including Illumina (Solexa) sequencing, Roche 454 sequencing, and Ion torrent: Proton/ PGM sequencing, SOLiD sequencing. Next-generation sequencing technologies have a number of advantages such as high speed, flexibility, high throughput, and reduced sequencing cost. Next-generation sequencing has ability to produce terabytes of nucleotide sequence data in a lone sequencing procedure. The NGS technology is developing at a rapid rate, owing to its rising adoption in scientific applications as it enables scanning of targeted genomes or whole genomes in lesser time. Moreover, decrease in cost of sequencing has also extended the procedure of next generation sequencing in various clinical applications. The technique has a variety of usages in diverse clinical applications such as inherited genetic disorders, cancer, identification of infectious diseases and HLA typing. For example, next-generation sequencing has been in use for tracing tuberculosis outbreaks and hospital acquired infections. These factors are projected to propel growth of the next-generation sequencing market over the forecast period (2016-2024).
According to an article published in the magazine Scientific American, whole genome testing might not give accurate results all the time. A low risk disease might take a shape and affect the person in his lifetime. However, gene sequencing is helpful in predicting diseases and in most cases, preventing them. In the era of increased health awareness and advanced technologies, people around the world are embracing the early detection techniques so that they can take care of the diseases such as cancer from an early stage. Next generation sequencing is primarily used to predict the diseases which are hereditary in nature.

Request a sample copy of this report@
https://www.coherentmarketinsights.com/insight/request-sample/158

Next-generation Sequencing Market Taxonomy
On the basis of technology, the global is classified into:

Sequencing By Synthesis (SBS),Sequencing By Ligation (SBL),ION Semiconductor Sequencing,Single-Molecule Real-Time Sequencing (SMRT),Pyrosequencing,Genomics,Whole Genome Sequencing,Exome Sequencing,De Novo Sequencing,Targeted Sequencing,Transcriptomics,Total RNA and mRNA Sequencing,Targeted RNA Sequencing,Small RNA and Non coding RNA SEQUENCIMG,Epigenomics,Methylation Sequencing,CHIP Sequencing,Ribosome Profiling,Other
On the basis of application, the global is classified into:,Diagnostics,Drug Discovery,Agriculture & Animal Research,Personalized Medicine,Biomarker Discovery,Others
On the basis of end user, the global is classified into:,Research Centers & Academic/Government Institutes,Hospitals & Clinics,Pharmaceutical & Biotechnology Companies,Others

According to global genes, there are 7,000 types of rare diseases in the world and 80% of these diseases are genetic in order. Moreover, as of 2013, 30 million people in the U.S. have rare diseases that accounts for around 10% of the total population of the country. It is estimated that 24 million people in the U.S. suffer from genetic or hereditary diseases. Since next-generation sequencing can be linked to a variety of diseases, its role in treatment is of utmost importance which will fuel the market growth of the market in the region. Moreover, technological advancements as well as development of efficient diagnostic tests will ensure early detection of these diseases, thereby augmenting growth of next-generation sequencing market.

Growing prevalence of hereditary diseases and government initiatives will drive the overall next-generation sequencing market
According to a report by Global Genes, in 2009, Europe accounted for around 30 million people of the 350 million people worldwide who suffered from some rare disease. Moreover, children accounted for around half the population affected by rare diseases. According to Net Wellness, more than 20% of the infant deaths are caused due to genetic disorder. These statistics are truly mind boggling and this would increase the demand for gene sequencing techniques thereby augmenting the overall growth of the next-generation sequencing market.

During the estimated period, Asia-Pacific market is likely to grow at the maximum rate owing technological innovation, rising drug discovery programs by healthcare companies, and growing adoption of pioneering treatment models are some of the prime factors that will drive the growth of market in the region. Moreover governments in these region are increasing their overall healthcare spends in their budgets owing to high prevalence of these diseases. This would result in increased initiatives by the healthcare companies and research organizations, in turn fueling growth of the next-generation sequencing market.

Some of the companies operating in the next-generation sequencing market in the current scenario are Life Sciences Corporation (Roche Holding Ag), Agilent Technologies, Life Technologies Corporation, Perkin Elmer, Genomatix Software Gmbh, Illumina, Inc., Genomatix Software Gmbh, Macrogen, Inc., Oxford Nanopore Technologies, Ltd., Gatc Biotech Ag, Dnastar, Inc., IncPartek Incorporated, Knome, Inc., and Qiagen N.V.

Request a sample copy of this report@
https://www.coherentmarketinsights.com/ongoing-insight/next-generation-sequencing-market-158

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next-generation Sequencing Market here

News-ID: 585569 • Views: 264

More Releases from Biotechnology Industry Report By CMI

The New Research Trial Drives The Shigella Vaccines Market
Shigella is a gram-negative pathogenic enterobacteria that causes severe diarrhea and dysentery in humans. Symptoms associated with Shigella infection includes fever, stomach pain, tenesmus, watery diarrhea, vomiting, dehydration, and convulsions. Various strains of Shigella are encompassed, such as S. dysenteriae, S. flexneri, S. sonnei and S. boydii. Each species of Shigella has different serotypes classified on the basis of the structure of O-antigens repeats that are the polysaccharides moiety of the lipopolysaccharide, a virulence
Flow Cytometry Market to Surpass US$ 7.64 Billion Threshold by 2025
Flow Cytometry – It’s not just for immunologist anymore Flow cytometry is a widely used method for analyzing the expression of cell surface and intracellular molecules. It can also characterize and define different cell types in a heterogeneous cell population. Moreover, flow cytometry also allows simultaneous multi-parameter analysis of single cells. The growth in flow cytometry market is mainly driven by the combination of technological improvements, growing research activities in life
Dental Bone Graft and Substitutes Market to Surpass US$ 911.4 Million Threshold …
Dental Bone Graft and Substitutes Market Insights Dental bone grafts are used as fillers or scaffolds that facilitate bone formation and helps in the wound healing and are suitable for a variety of clinical procedures such as filling of sockets, preservation of ridge volume (also referred to as ridge preservation), and osteogenesis i.e., the formation of new bones. Dental bone grafts are bioresorbable and are not reactive to antigen-antibody. Bone grafts
Dental Bone Graft and Substitutes Market to Surpass US$ 911.4 Million Threshold …
Dental Bone Graft and Substitutes Market Insights Dental bone grafts are used as fillers or scaffolds that facilitate bone formation and helps in the wound healing and are suitable for a variety of clinical procedures such as filling of sockets, preservation of ridge volume (also referred to as ridge preservation), and osteogenesis i.e., the formation of new bones. Dental bone grafts are bioresorbable and are not reactive to antigen-antibody. Bone grafts

All 5 Releases


More Releases for Sequencing

Precision Medicine Market Report 2018: Segmentation by Technology (Genomics, Tra …
Global Precision Medicine market research report provides company profile for Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, Pfizer Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Next Wave in DNA Sequencing Market
Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used by researchers and scientist globally. This technology offers a massive sequence throughput at modest costs in a single sequencing run. DNA Sequencing Market was valued at $5,156 million in 2016 and is expected to reach $18,284 million in 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing is a technology in
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno …
ReportsWeb.com has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the
Next Generation Sequencing Market By Key Manufacturers (Illumina, Qiagen, Perkin …
Next generation sequencing (NGS) is the technology which is used to align millions of small fragments of DNA simultaneously that are capable of processing multiple DNA sequences in parallel. The arrival of rapid DNA sequencing methods has significantly enhanced biological and medical research and discovery. The next generation sequencing market is anticipated to grow at a CAGR of 21.1% and reach US$ 26.5Bn by 2025. Increasing application of NGS in clinical
Pyro Sequencing Market: Business Intelligence & Market Insights
Pyro sequencing is a DNA sequencing technology based on the principle of sequencing-by-synthesis. The method consist of series of four enzymatic steps to detect sequence of nuclei acid during synthesis. Pyro sequencing can be easily automated and provides highly accurate results. The method is highly suitable for analysis of single nucleotide polymorphism and sequencing of small fragment of DNA. Pyro sequencing techniques consist of series of sequential steps for detection
Global DNA Sequencing Market Report
MarketResearchReports.Biz announces addition of new report “Global DNA Sequencing Market Report: 2015 Edition” to its database. Description DNA sequencing market is one of the fastest growing segments of the life sciences tools market. This research study includes the market assessment of various products, technologies, applications and end-users. The report briefs about the classification in genomics, process of transcription and translation of DNA, historical development, and generations of sequencing technologies. The sequencing industry is